Ana Limon

SVP Clinical Development and Global Medical Affairs at Oryzon Genomics

Role
SVP Clinical Development and Gma at Oryzon Genomics Sa
Location
Boston, MA, US
LinkedIn followers
500 followers
Healthcare & Human ServicesView LinkedIn profile

About Ana Limon

A creative, proactive and result driven professional, with exceptional leadership, initiative, productivity, and communication skills. Outstanding strategic thinking, ability to set plans, anticipate challenges, solve issues and build relationships with international Key Opinion Leaders and Research institutions/Networks at the basic, translational and clinical research levels. Able to coordinate complex matrix environment and lead multifunctional teams with consistently proven ability to meet tight deadlines. Member of E-team, involved in Board discussions, Budget Plans, Business Development and Investor Meeting activities. Clinical Development, Product Lead and Medical affairs Leadership positions held in Biotech and Big Pharma. As Head of Clinical Sciences and Global Product Lead, worked on the planning and implementation of the strategic development of assets from DC nomination, IND to clinical studies defining the path to registration. Expertise in global regulatory requirements and interactions with regulatory agencies. As Global Medical affairs Head of the Oncology pipeline in a Top 15 Pharma Company created the Global Medical Strategy plan for several pipeline molecules. Lead KOL engagement initiatives, Advisory Boards, Medical External Communication, Publication Plans and External Partnership Alliances and Research Collaborations. Additionally lead the Investigator Initiated Studies Program and Life Cycle Management for commercial assets in Oncology including Field Scientific activities and Real-World Evidence studies. Research expertise in Hematology and Solid tumor Clinical Oncology, Molecular Biology, Tumor biology, Stem cell biology, Immunology, Virology, Gene and Cell therapy.Academic and research expertise in molecular biology, virology, tumor biology, angiogenesis, gene therapy and tumor stem cell biology. Outstanding ability to communicate scientific and clinical concepts and experience in building relationships with international oncology KOLs at the basic and clinical research levels. Able to coordinate complex matrix environment and lead multifunctional teams with consistently proven ability to meet tight deadlines. Management and training expertise in academia and industry.

Experience

  1. SVP Clinical Development and Gma

    Oryzon Genomics Sa

    Jan 2022 — Present · Boston, MA, US

    Development of innovative epigenetic drugs in Oncology and CNS indications

Education

  • University of Barcelona

    PhD, Pharmacy, Biochemistry and Molecular Biology

    1984 — 1992

Skills

  • Immunology
  • Clinical Development
  • Western Blotting
  • Lifesciences
  • Life Sciences
  • In Vitro
  • Pharmaceutical Industry
  • Cell
  • In Vivo
  • Clinical Research
  • Drug Discovery
  • Cell Biology
  • Cell Based Assays
  • Biomarkers
  • Therapeutics
  • Medical Affairs
  • Clinical Trials
  • Elisa
  • Pharmacology
  • Cell Culture
  • Drug Development
  • Infectious Diseases
  • Cancer
  • Biopharmaceuticals
  • Immunohistochemistry
  • Oncology
  • Hematology
  • Transfection
  • Biotechnology

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Ana Limon — SVP Clinical Development and Gma at Oryzon Genomics Sa in Boston, MA, US | Unifers